Eric Bednarski is a partner at MVM, a growth equity firm that invests in innovative healthcare companies. Prior to MVM, Mr. Bednarski was a partner at Advent Healthcare Ventures and a principal at Advent International Corporation. Before Advent, Eric was a director in the Corporate Finance Group of Silicon Valley Bank. Eric has a bachelor’s degree in neural science from Brown University and a Ph.D. in biological sciences from the University of California, Irvine. In addition to Newton, Eric is a member of the board of MDxHealth SA (NASDAQ: MDXH), OptiNose, Inc. (NASDAQ: OPTN), and Vero Biotech, Inc. He was previously a director for AccuVein, Inc., Ambio, Inc., Biotheranostics, Inc. (acquired by Hologic) and Heptares Ltd (acquired by Sosei Group Corporation).